Αρχειοθήκη ιστολογίου

Τρίτη 20 Ιουλίου 2021

Aesthesiometer‐Based Testing for Laryngopharyngeal Hyposensitivity

xlomafota13 shared this article with you from Inoreader

Objectives/Hypothesis

To develop a method for threshold estimation of the laryngeal adductor reflex (LAR) response using Cheung-Bearelly monofilaments.

Study Design

Cross-sectional.

Methods

Twenty-two healthy adults (12 men, 10 women) were tested for LAR response outcome using 30 mm 5–0 and 4–0 nylon monofilaments. Tactile stimuli were delivered to the aryepiglottic (AE) fold and medial pyriform sinus (MPS). Dichotomous classifier features and performance (area under the curve (AUC)), the LAR response outcome agreement and disagreement matrix, and test–retest reliability were examined. From those data, a test protocol that would minimize patient burden to estimate the LAR triggering threshold was formulated.

Results

Classifier performance of 5–0 monofilament stimulation of the AE fold (sensitivity = 0.63, specificity = 0.63, PPV = 0.74, NPV = 0.25) and MPS (sensitivity = 0.45, specificity = 0.77, PPV = 0.74, NPV = 0.23,) was slightly below that of 4–0 monofilament stimulation of the AE fold (sensitivity = 0.82, specificity = 0.50, PPV = 0.82, NPV = 0.50) and MPS (sensitivity = 0.84, specificity = 0.64, PPV = 0.90, NPV = 0.56), based on AUC. LAR response outcome agreement for 5–0 and 4–0 stimulations was high (93%) for 5–0 positive response, but low (29%) for 5–0 negative response. Aesthesiometer test–retest reliability for LAR response outcome was excellent (Cronbach's alpha = 0.97).

Conclusions

Threshold estimation of the LAR response may be operationalized by adopting a decision tree protocol. For negative LAR response to initial 5–0 monofilament stimulation and positive response to subsequent 4–0 monofilament stimulation, the higher threshold is confirmed. Positive LAR response to 5–0 or 4–0 monofilament stimulation is expected in over 90% of asymptomatic adults. Negative LAR response to 4–0 monofilament stimulation identifies patients at risk for laryngopharyngeal hyposensitivity.

Level of Evidence

3b Laryngoscope, 2021

View on the web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου